Account-creators
1,040
edits
Difference between revisions of "Epidermal growth factor receptor inhibitors"
Jump to navigation
Jump to search
Epidermal growth factor receptor inhibitors (view source)
Revision as of 09:41, 13 February 2020
, 09:41, 13 February 2020mutations
Jensflorian (talk | contribs) (EGFR) |
Jensflorian (talk | contribs) (mutations) |
||
| Line 4: | Line 4: | ||
*EGFR (aka. ErbB1 or HER1) is a membranous receptor expressed in epithelial cells. | *EGFR (aka. ErbB1 or HER1) is a membranous receptor expressed in epithelial cells. | ||
*Most of activating mutations in [[NSCLC]] are in Exon 18-21 (kinase domain). | *Most of activating mutations in [[NSCLC]] are in Exon 18-21 (kinase domain). | ||
*45% of the mutations are p.DEL19, approx 40-45% are p.L858R, approx 2% are p.T790M. | |||
==Drugs== | ==Drugs== | ||